NewsEli Lilly to Acquire SiteOne Therapeutics for ~$1B, Strengthening its Pain PipelineByRidhi RastogiMay 28, 20250Comments
NewsAstraZeneca Reports the CHMP’s Positive Opinion for Perioperative Imfinzi to Treat Muscle-Invasive Bladder Cancer (MIBC)ByRidhi RastogiMay 27, 20250Comments
NewsRemeGen’s Telitacicept Receives the NMPA’s Approval for Generalized Myasthenia Gravis (gMG)ByRidhi RastogiMay 27, 20250Comments
NewsGSK Reports Health Canada’s NDS Acceptance of Depemokimab for Asthma with Type 2 Inflammation and CRSwNPByRidhi RastogiMay 27, 20250Comments
NewsFresenius kabi Secures the CHMP’s Positive Opinion for Bomyntra & Conexxence (Biosimilar, Prolia and Xgeva)ByDipanshu DixitMay 27, 20250Comments
NewsAI Medical Technology’s Dermalyser Receives European CE Mark Approval for Melanoma DetectionByRidhi RastogiMay 27, 20250Comments
NewsBio-Thera Solutions and Hikma Pharmaceuticals Receive the US FDA’s Approval for Starjemza (Biosimilar, Stelara)ByRidhi RastogiMay 27, 20250Comments
